Foster Dykema Cabot & Co’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $26K | Sell |
127
-21
| -14% | -$4.43K | ﹤0.01% | 188 |
|
|
2023
Q2 | $31K | Hold |
148
| – | – | ﹤0.01% | 183 |
|
|
2023
Q1 | $29K | Buy |
+148
| New | +$30.5K | ﹤0.01% | 168 |
|
|
2022
Q4 | – | Sell |
-1,538
| Closed | -$271K | – | 93 |
|
|
2022
Q3 | $271K | Hold |
1,538
| – | – | 0.03% | 72 |
|
|
2022
Q2 | $310K | Hold |
1,538
| – | – | 0.04% | 70 |
|
|
2022
Q1 | $348K | Hold |
1,538
| – | – | 0.04% | 79 |
|
|
2021
Q4 | $415K | Hold |
1,538
| – | – | 0.05% | 72 |
|
|
2021
Q3 | $372K | Hold |
1,538
| – | – | 0.05% | 73 |
|
|
2021
Q2 | $364K | Hold |
1,538
| – | – | 0.05% | 73 |
|
|
2021
Q1 | $337K | Sell |
1,538
-123
| -7% | -$24.7K | 0.05% | 70 |
|
|
2020
Q4 | $290K | Sell |
1,661
-9
| -0.5% | -$1.55K | 0.04% | 82 |
|
|
2020
Q3 | $270K | Sell |
1,670
-7
| -0.4% | -$1.11K | 0.04% | 76 |
|
|
2020
Q2 | $239K | Buy |
+1,677
| New | +$232K | 0.04% | 81 |
|
|
2020
Q1 | – | Sell |
-1,713
| Closed | -$249K | – | 95 |
|
|
2019
Q4 | $249K | Sell |
1,713
-6
| -0.3% | -$866 | 0.04% | 87 |
|
|
2019
Q3 | $248K | Sell |
1,719
-1,015
| -37% | -$148K | 0.04% | 91 |
|
|
2019
Q2 | $406K | Hold |
2,734
| – | – | 0.06% | 79 |
|
|
2019
Q1 | $359K | Sell |
2,734
-53
| -2% | -$6.53K | 0.06% | 79 |
|
|
2018
Q4 | $303K | Buy |
2,787
+850
| +44% | +$114K | 0.05% | 81 |
|
|
2018
Q3 | $289K | Sell |
1,937
-850
| -30% | -$129K | 0.05% | 87 |
|
|
2018
Q2 | $413K | Hold |
2,787
| – | – | 0.07% | 75 |
|
|
2018
Q1 | $387K | Sell |
2,787
-568
| -17% | -$83.4K | 0.07% | 79 |
|
|
2017
Q4 | $460K | Sell |
3,355
-81
| -2% | -$10.7K | 0.08% | 74 |
|
|
2017
Q3 | $446K | Hold |
3,436
| – | – | 0.08% | 70 |
|
|
2017
Q2 | $455K | Sell |
3,436
-1,775
| -34% | -$217K | 0.08% | 77 |
|
|
2017
Q1 | $642K | Hold |
5,211
| – | – | 0.12% | 60 |
|
|
2016
Q4 | $575K | Sell |
5,211
-268
| -5% | -$29.8K | 0.11% | 65 |
|
|
2016
Q3 | $647K | Sell |
5,479
-349
| -6% | -$41.1K | 0.14% | 63 |
|
|
2016
Q2 | $652K | Sell |
5,828
-797
| -12% | -$85.8K | 0.15% | 55 |
|
|
2016
Q1 | $667K | Sell |
6,625
-387
| -6% | -$37.1K | 0.16% | 50 |
|
|
2015
Q4 | $745K | Sell |
7,012
-184
| -3% | -$19K | 0.19% | 46 |
|
|
2015
Q3 | $671K | Hold |
7,196
| – | – | 0.17% | 46 |
|
|
2015
Q2 | $749K | Sell |
7,196
-1,443
| -17% | -$150K | 0.19% | 44 |
|
|
2015
Q1 | $936K | Hold |
8,639
| – | – | 0.23% | 43 |
|
|
2014
Q4 | $801K | Sell |
8,639
-140
| -2% | -$12.4K | 0.19% | 46 |
|
|
2014
Q3 | $767K | Hold |
8,779
| – | – | 0.19% | 44 |
|
|
2014
Q2 | $772K | Sell |
8,779
-407
| -4% | -$35.3K | 0.18% | 46 |
|
|
2014
Q1 | $775K | Sell |
9,186
-2,200
| -19% | -$175K | 0.19% | 43 |
|
|
2013
Q4 | $894K | Sell |
11,386
-233
| -2% | -$19.9K | 0.24% | 42 |
|
|
2013
Q3 | $990K | Sell |
11,619
-35
| -0.3% | -$2.95K | 0.29% | 38 |
|
|
2013
Q2 | $1M | Buy |
+11,654
| New | +$968K | 0.3% | 36 |
|
Other funds holding LH
Foster Dykema Cabot & Co's LH Position: Q3 2023 in Review
Foster Dykema Cabot & Co reduced its Labcorp (LH) stake by 14% in Q3 2023, selling an estimated $4.43K and leaving 127 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #188.
Foster Dykema Cabot & Co first reported a position in LH in Q2 2013 and has held it in 40 quarters since. The position peaked at $1M in Q2 2013. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.
- Foster Dykema Cabot & Co held 127 shares of Labcorp worth $26K as of Q3 2023.
- Foster Dykema Cabot & Co sold 21 Labcorp shares in Q3 2023, an estimated $4.43K.
- Labcorp made up ﹤0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #188 holding.
- Foster Dykema Cabot & Co first reported a position in Labcorp in Q2 2013 and has held it in 40 quarters since.
- Foster Dykema Cabot & Co's Labcorp position peaked at $1M in Q2 2013.
- 881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.
Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.